Your Article Summary
See Latest ArticlesThree-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy
Current Medical Research and Opinion, 06/19/09
Nixon DR et al. - Fixed-combination brimonidine–timolol provided the same or greater IOP lowering compared with fixed-combination dorzolamide–timolol. Both fixed-combination medications were safe and well-tolerated. Brimonidine–timolol received higher ratings of ocular comfort than dorzolamide–timolol. The duration of the studies was 3 months, and additional studies will be needed to compare the efficacy and tolerability of brimonidine–timolol and dorzolamide–timolol during long-term treatment.
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09
Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Annals of Pharmacotherapy, 12/16/09
'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09